4
Changes in Ownership
ZEVRA THERAPEUTICS, INC. Filed Acc 0001209191-15-035355
Exec VP R&D acquired 23,852 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Guenther Sven · Exec VP R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-04-21 | Conversion : show line 1 in the form | +23,852 | 43,852 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2015-04-21 | Conversion : show line 2 in the form Series A Convertible Preferred Stock | −26,355 | 3,514 | 0 | D |
| 2015-04-21 | Conversion : show line 3 in the form Series B Convertible Preferred Stock | −16,129 | 2,150 | 0 | D |
| 2015-04-21 | Conversion : show line 4 in the form Series C Convertible Preferred Stock | −136,410 | 18,188 | 0 | D |
Loading xslF345X03/doc4.xml…